Identification of the couple GSK3α/c-Myc as a new regulator of hexokinase II in benzo[a]pyrene-induced apoptosis

Toxicology in Vitro

Volumn 26, Issue 1, 2012, Pages 94-101

  Dendelé, Béatrice ^a   Tekpli, Xavier ^a,c   Sergent, Odile ^a   Dimanche Boitrel, Marie Thérèse ^a   Holme, Jørn A ^b   Huc, Laurence ^a,d   Lagadic Gossmann, Dominique ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^d NONE   (France)

Author keywords

Apoptosis; Benzo a pyrene; C Myc; GSK3; Hexokinase II; Mitochondria; NHE1

Indexed keywords

BENZO[A]PYRENE; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; HEXOKINASE; HEXOKINASE 2; MYC PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENICITY; CELL CYCLE ARREST; CELL ENERGY; CELL LEVEL; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DISEASE ACTIVITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME RELEASE; EPITHELIUM CELL; INTRACELLULAR SIGNALING; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEIN TRANSPORT; RAT;

RATTUS;

EID: 84855339716     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.11.001     Document Type: Article

References (38)

1. Ahn K.J., Hwang H.S., Park J.H., Bang S.H., Kang W.J., Yun M., Lee J.D. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines. J. Nucl. Med. 2009, 50:1525-1532.
2. Beurel E., Jope R.S. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 2006, 79:173-189.
3. Bijur G.N., De Sarno P., Jope R.S. Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J. Biol. Chem. 2000, 275:7583-7590.
4. Cao Z., Fan-Minogue H., Bellovin D.I., Yevtodiyenko A., Arzeno J., Yang Q., Gambhir S.S., Felsher D.W. MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer Res. 2011, 71:2286-2297.
5. Ciani L., Salinas P.C. WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat. Rev. Neurosci. 2005, 6:351-362.
6. Dang C.V., Le A., Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 2009, 15:6479-6483.
7. Das S., Wong R., Rajapakse N., Murphy E., Steenbergen C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ. Res. 2008, 103:983-991.
8. Ding V.W., Chen R.H., McCormick F. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J. Biol. Chem. 2000, 275:32475-32481.
9. Feyt C., Kienlen-Campard P., Leroy K., N'Kuli F., Courtoy P.J., Brion J.P., Octave J.N. Lithium chloride increases the production of amyloid-beta peptide independently from its inhibition of glycogen synthase kinase 3. J. Biol. Chem. 2005, 280:33220-33227.
10. Fields W.R., Desiderio J.G., Leonard R.M., Burger E.E., Brown B.G., Doolittle D.J. Differential c-myc expression profiles in normal human bronchial epithelial cells following treatment with benzo[a]pyrene, benzo[a]pyrene-4, 5 epoxide, and benzo[a]pyrene-7, 8-9, 10 diol epoxide. Mol. Carcinog. 2004, 40:79-89.
11. Force T., Woodgett J.R. Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J. Biol. Chem. 2009, 284:9643-9647.
12. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 2001, 359:1-16.
13. Gregory M.A., Qi Y., Hann S.R. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J. Biol. Chem. 2003, 278:51606-51612.
14. Hernandez-Davies J.E., Zape J.P., Landaw E.M., Tan X., Presnell A., Griffith D.J., Heinrich M.C., Glaser K.B., Sakamoto K.M. The multi-targeted receptor tyrosine kinase inhibitor, Linifanib (ABT-869), induces apoptosis through an AKT and Glycogen Synthase Kinase 3{beta}-dependent pathway. Mol. Cancer Ther. 2011, 10:949-959.
15. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 2000, 406:86-90.
16. Huc L., Rissel M., Solhaug A., Tekpli X., Gorria M., Torriglia A., Holme J.A., Dimanche-Boitrel M.T., Lagadic-Gossmann D. Multiple apoptotic pathways induced by p53-dependent acidification in benzo[a]pyrene-exposed hepatic F258 cells. J. Cell. Physiol. 2006, 208:527-537.
17. Huc L., Sparfel L., Rissel M., Dimanche-Boitrel M.T., Guillouzo A., Fardel O., Lagadic-Gossmann D. Identification of Na+/H+ exchange as a new target for toxic polycyclic aromatic hydrocarbons. FASEB J. 2004, 18:344-346.
18. Huc L., Tekpli X., Holme J.A., Rissel M., Solhaug A., Gardyn C., Le Moigne G., Gorria M., Dimanche-Boitrel M.T., Lagadic-Gossmann D. C-Jun NH2-terminal kinase-related Na+/H+ exchanger isoform 1 activation controls hexokinase II expression in benzo(a)pyrene-induced apoptosis. Cancer Res. 2007, 67:1696-1705.
19. Kim J.W., Gao P., Liu Y.C., Semenza G.L., Dang C.V. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol. 2007, 27:7381-7393.
20. Kim L., Kimmel A.R. GSK3, a master switch regulating cell-fate specification and tumorigenesis. Curr. Opin. Genet. Dev. 2000, 10:508-514.
21. Kotliarova S., Pastorino S., Kovell L.C., Kotliarov Y., Song H., Zhang W., Bailey R., Maric D., Zenklusen J.C., Lee J., Fine H.A. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res. 2008, 68:6643-6651.
22. Markou T., Cullingford T.E., Giraldo A., Weiss S.C., Alsafi A., Fuller S.J., Clerk A., Sugden P.H. Glycogen synthase kinases 3alpha and 3beta in cardiac myocytes: regulation and consequences of their inhibition. Cell. Signal. 2008, 20:206-218.
23. Mathupala S.P., Rempel A., Pedersen P.L. Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J. Biol. Chem. 2001, 276:43407-43412.
24. Matsuda T., Zhai P., Maejima Y., Hong C., Gao S., Tian B., Goto K., Takagi H., Tamamori-Adachi M., Kitajima S., Sadoshima J. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20900-20905.
25. Pastorino J.G., Hoek J.B. Hexokinase II: the integration of energy metabolism and control of apoptosis. Curr. Med. Chem. 2003, 10:1535-1551.
26. Pastorino J.G., Hoek J.B., Shulga N. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res. 2005, 65:10545-10554.
27. Peng S.Y., Lai P.L., Pan H.W., Hsiao L.P., Hsu H.C. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis. Oncol. Rep. 2008, 19:1045-1053.
28. Plas D.R., Rathmell J.C., Thompson C.B. Homeostatic control of lymphocyte survival: potential origins and implications. Nat. Immunol. 2002, 3:515-521.
29. Podar K., Anderson K.C. A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways. Cell Cycle 2010, 9:1722-1728.
30. Salas V.M., Burchiel S.W. Apoptosis in Daudi human B cells in response to benzo[a]pyrene and benzo[a]pyrene-7, 8-dihydrodiol. Toxicol. Appl. Pharmacol. 1998, 151:367-376.
31. Solhaug A., Refsnes M., Holme J.A. Role of cell signalling involved in induction of apoptosis by benzo[a]pyrene and cyclopenta[c, d]pyrene in Hepa1c1c7 cells. J. Cell. Biochem. 2004, 93:1143-1154.
32. Spokoini R., Kfir-Erenfeld S., Yefenof E., Sionov R.V. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis. Mol. Endocrinol. 2010, 24:1136-1150.
33. Tekpli X., Rissel M., Huc L., Catheline D., Sergent O., Rioux V., Legrand P., Holme J.A., Dimanche-Boitrel M.T., Lagadic-Gossmann D. Membrane remodeling, an early event in benzo[a]pyrene-induced apoptosis. Toxicol. Appl. Pharmacol. 2010, 243:68-76.
34. Valera A., Pujol A., Gregori X., Riu E., Visa J., Bosch F. Evidence from transgenic mice that myc regulates hepatic glycolysis. FASEB J. 1995, 9:1067-1078.
35. Vene R., Larghero P., Arena G., Sporn M.B., Albini A., Tosetti F. Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids. Cancer Res. 2008, 68:6987-6996.
36. Zedeck M.S. Polycyclic aromatic hydrocarbons: a review. J. Environ. Pathol. Toxicol. 1980, 3:537-567.
37. Zhai P., Gao S., Holle E., Yu X., Yatani A., Wagner T., Sadoshima J. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases. J. Biol. Chem. 2007, 282:33181-33191.
38. Zhao W., Ramos K.S. Modulation of Hepatocyte Gene Expression by the Carcinogen Benzo[a]pyrene. Toxicol. In Vitro 1998, 12:395-402.